Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR)

92 filings reported holding BNR - Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share as of Q3 2021.
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 27,470,929 shares .
Largest 10 shareholders include BAILLIE GIFFORD & CO (8,792,152 shares), MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC (1,990,408 shares), ORBIMED ADVISORS LLC (1,856,201 shares), BlackRock Inc. (1,839,228 shares), CANADA PENSION PLAN INVESTMENT BOARD (1,238,000 shares), VANGUARD GROUP INC (1,071,701 shares), Sumitomo Mitsui Trust Holdings, Inc. (1,019,339 shares), Nikko Asset Management Americas, Inc. (919,425 shares), AMERIPRISE FINANCIAL INC (891,627 shares), and MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (723,473 shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.